home > about us > the consortium
The Consortium
By joining Simcyp, you will become part of the Simcyp Consortium. The Consortium includes leading pharmaceutical and biotechnology companies, regulatory authorities and academic centres.
Members of the Consortium not only gain access to Simcyp’s latest products and consultancy services, but can also contribute to the development of the services offered. The Consortium acts as a steering committee to ensure that new Simcyp products and services are relevant to the current and future needs of the members.
Members of the Consortium Include:
Pharmaceutical: AstraZeneca, Biovitrum, Daiichi-Sankyo, F.Hoffman-La Roche, Eli Lilly, Lundbeck, Johnson & Johnson Pharmaceutical Research and Development, Novartis Pharma, Nycomed, Otsuka, Pfizer, sanofi-aventis, Servier, Takeda, UCB
Academic: Childrens Mercy Hospitals & Clinics, China Pharmaceutical University, Showa Pharmaceutical University, Showa University, Universite de la Mediterranee, University of Aberdeen, University of Buffalo, University of Göteborg, University of Lisbon, University of Malta, University of Manchester, University of Uppsala
Non Profit Organisations: European Centre for the Validation of Alternative Methods (ECVAM - Italy), Swedish Medical Products Agency (MPA), Finnish National Agency for Medicines (NAM).
Simcyp is also in continual dialogue with the US Food & Drug Administration (FDA).
Each year, Consortium Members are invited to a meeting at which they provide feedback on their use of the Simcyp Simulator and suggest any features/improvements that they would like adding to the platform.
At each meeting, the Simcyp team presents updates to the databases and Simulator as well as proposals for further development. A list of features is agreed by the Consortium with priorities for the Simcyp team to work on.
Consortium Members receive all new releases of the Simcyp Simulator and access to the Simcyp science team for consultancy on specific issues.
Each year Consortium Members are invited to Focus Group Meetings which tackle specific problems in the area of in vitro-in vivo extrapolation (IVIVE). Previous topics include: Non specific Microsomal Binding (July 2005), Intersystem Extrapolation Factors (April 2006), Assessment of CYP Induction in vitro (June 2006) and Modelling Hepatic and Biliary Transporters (July 2006).
Consortium Members also have access to the members' area of the Simcyp website, with downloads of the latest version of the Simulator and a users' forum.
To join our Consortium and share in its contributions to state-of-the-art drug development, please come to one of our workshops, where you will learn more about the Simcyp Simulator and the services we offer.